Cargando…
Single-cell transcriptome sequencing reveals potential novel combination of biomarkers for antibody-based cancer therapeutics in hepatocellular carcinoma
Background: Antibody-based cancer therapeutics is developing rapidly in recent years for its advantages in precisely targeting the tumor cells. However, tumor-specific cell surface antigens are still lacking, and the heterogeneity of tumor mass greatly impeded the development of effective drugs. Met...
Autores principales: | Tang, Hong, Yuan, Jun, Gong, Yuan-Feng, Zhang, Cheng-Yang, Liu, Ming, Luo, Su-Xia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9515615/ https://www.ncbi.nlm.nih.gov/pubmed/36186483 http://dx.doi.org/10.3389/fgene.2022.928256 |
Ejemplares similares
-
Combining Single-Cell and Transcriptomic Data Revealed the Prognostic Significance of Glycolysis in Pancreatic Cancer
por: Chen, Liang, et al.
Publicado: (2022) -
Identification of biomarkers for hepatocellular carcinoma based on single cell sequencing and machine learning algorithms
por: Li, Weimin, et al.
Publicado: (2022) -
Prognosis and personalized medicine prediction by integrated whole exome and transcriptome sequencing of hepatocellular carcinoma
por: Li, Debao, et al.
Publicado: (2023) -
Reviving the Transcriptome Studies: An Insight Into the Emergence of Single-Molecule Transcriptome Sequencing
por: Wang, Bo, et al.
Publicado: (2019) -
Transcriptome Sequencing Unravels Potential Biomarkers at Different Stages of Cerebral Ischemic Stroke
por: Cai, You, et al.
Publicado: (2019)